Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2012 1
2013 3
2014 6
2015 6
2016 2
2017 2
2018 4
2019 5
2020 12
2021 12
2022 9
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Characterization and antiproliferative activity of glioma-derived extracellular vesicles.
Scholl JN, de Fraga Dias A, Pizzato PR, Lopes DV, Moritz CEJ, Jandrey EHF, Souto GD, Colombo M, Rohden F, Sévigny J, Pohlmann AR, Guterres SS, Battastini AMO, Figueiró F. Scholl JN, et al. Among authors: figueiro f. Nanomedicine (Lond). 2020 Apr;15(10):1001-1018. doi: 10.2217/nnm-2019-0431. Epub 2020 Apr 6. Nanomedicine (Lond). 2020. PMID: 32249669
CD39 and CD73 as Promising Therapeutic Targets: What Could Be the Limitations?
Battastini AMO, Figueiró F, Leal DBR, Doleski PH, Schetinger MRC. Battastini AMO, et al. Among authors: figueiro f. Front Pharmacol. 2021 Mar 11;12:633603. doi: 10.3389/fphar.2021.633603. eCollection 2021. Front Pharmacol. 2021. PMID: 33815115 Free PMC article. No abstract available.
Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients.
Pietrobon AJ, Andrejew R, Custódio RWA, Oliveira LM, Scholl JN, Teixeira FME, de Brito CA, Glaser T, Kazmierski J, Goffinet C, Turdo AC, Yendo T, Aoki V, Figueiró F, Battastini AM, Ulrich H, Benard G, Duarte AJDS, Sato MN. Pietrobon AJ, et al. Among authors: figueiro f. Front Immunol. 2022 Sep 30;13:1012027. doi: 10.3389/fimmu.2022.1012027. eCollection 2022. Front Immunol. 2022. PMID: 36248842 Free PMC article.
Development of bozepinib-loaded nanocapsules for nose-to-brain delivery: preclinical evaluation in glioblastoma.
Fraga Dias A, Dallemole DR, Bruinsmann FA, Lopes Silva LF, Cruz-López O, Conejo-García A, Oliveira Battastini AM, Campos JM, Guterres SS, Pohlmann AR, Figueiró F. Fraga Dias A, et al. Among authors: figueiro f. Nanomedicine (Lond). 2021 Oct;16(23):2095-2115. doi: 10.2217/nnm-2021-0164. Epub 2021 Sep 15. Nanomedicine (Lond). 2021. PMID: 34523353
P2Y12 receptor antagonism inhibits proliferation, migration and leads to autophagy of glioblastoma cells.
Vargas P, Scheffel TB, Diz FM, Rockenbach L, Grave N, Cappellari AR, Kist LW, Bogo MR, Thomé MP, Leal GF, de Fraga Dias A, Figueiró F, Filippi-Chiela EC, Lenz G, Morrone FB. Vargas P, et al. Among authors: figueiro f. Purinergic Signal. 2022 Dec;18(4):481-494. doi: 10.1007/s11302-022-09888-w. Epub 2022 Aug 8. Purinergic Signal. 2022. PMID: 35939198 Free PMC article.
Exploring CD39 and CD73 Expression as Potential Biomarkers in Prostate Cancer.
Gardani CFF, Pedrazza EL, Paz VS, Zanirati GG, da Costa JC, Andrejew R, Ulrich H, Scholl JN, Figueiró F, Rockenbach L, Morrone FB. Gardani CFF, et al. Among authors: figueiro f. Pharmaceuticals (Basel). 2023 Nov 16;16(11):1619. doi: 10.3390/ph16111619. Pharmaceuticals (Basel). 2023. PMID: 38004484 Free PMC article.
68 results